Improvement of the novel inhibitor for Mycobacterium enoyl-acyl carrier protein reductase (InhA): a structure–activity relationship study of KES4 assisted by in silico structure-based drug screening-Reference-Cited by-同舟云学术

Improvement of the novel inhibitor for Mycobacterium enoyl-acyl carrier protein reductase (InhA): a structure–activity relationship study of KES4 assisted by in silico structure-based drug screening

Published:2020-03-09 Issue:6 Volume:73 Page:372-381
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Taira Junichi,Umei Tomohiro,Inoue Keitaro,Kitamura Mitsuru,Berenger Francois,Sacchettini James C.^ORCID,Sakamoto Hiroshi,Aoki Shunsuke

Funder

Takeda Science Foundation

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

http://www.nature.com/articles/s41429-020-0293-6.pdf

Reference31 articles.

1. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science. 2010;328:856–61.

2. Das P, Horton R. Tuberculosis-time to accelerate progress. Lancet. 2010;375:1755–7.

3. Das P, Horton R. Tuberculosis-getting to zero. Lancet. 2015;386:2231–2.

4. Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375:1814–29.

5. Sotgiu G, Centis R, D’Ambrosio L, Migliori GB. Tuberculosis treatment and drug regimens. Cold Spring Harb Perspect Med. 2015;5:a017822.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, in vitro and in silico screening of novel ferrocenyl substituted cyclohexenone and indazole derivatives as effective antimycobacterial agents;Journal of Molecular Structure;2024-09

2. Decarboxylation and Tandem Reduction/Decarboxylation Pathways to Substituted Phenols from Aromatic Carboxylic Acids Using Bimetallic Nanoparticles on Supported Ionic Liquid Phases as Multifunctional Catalysts;Journal of the American Chemical Society;2023-10-10

3. Identification of novel inhibitors for mycobacterial polyketide synthase 13 via in silico drug screening assisted by the parallel compound screening with genetic algorithm-based programs;The Journal of Antibiotics;2022-08-08

4. Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence;Journal of Biomolecular Structure and Dynamics;2022-06-24

5. Triclosan Induced Oxidative Stress, Estrogenicity, Mutagenicity, Carcinogenicity, and Genotoxicity: A Novel Therapeutic Approach;Biomedical Research and Therapy;2021-12-30